Goss Wealth Management »

Travere Therapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $125k 15k 8.22
2022-12-31 $0 13 0.00

More positions owned by Goss Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Goss Wealth Management

Top funds holding Travere Therapeutics

BlackRock
BlackRock
Armistice Capital
Deep Track Capital
Vanguard Group
Rock Springs Capital Management
Macquarie Group
Woodline Partners
State Street Corporation
Morgan Stanley
Kynam Capital Management
Emerald Advisers
Renaissance Technologies
D. E. Shaw & Co
Bank of America Corporation

View all funds holding Travere Therapeutics